Markets › United States › NYSE › CRL

Charles River Laboratories International Inc

NYSE:CRLHealthcareCBOE:SPESGNASDAQ:NQUSMG

$300.02−0.04%At closeAt close · Tue 20 Oct · ≈ AED 1,101.82 · Market cap $14.32B · Next earnings Wed 4 Nov

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-05	2.74	−0.03	−101.1%	977.2	1,004.1	+2.8%
2026-05-07	1.96	2.06	+5.1%	977.5	995.8	+1.9%
2026-02-18	2.33	2.39	+2.6%	987.0	994.2	+0.7%
2025-11-05	2.32	2.43	+4.7%	987.2	1,004.9	+1.8%
2025-08-06	2.50	3.12	+24.8%	968.9	1,032.1	+6.5%
2025-05-07	2.06	2.34	+13.6%	958.8	984.2	+2.6%
2025-02-19	2.50	2.66	+6.4%	948.2	1,002.5	+5.7%
2024-11-06	2.42	2.59	+7.0%	976.0	1,009.8	+3.5%
2024-08-07	2.39	2.80	+17.2%	1,024.3	1,026.1	+0.2%
2024-05-09	2.06	2.27	+10.2%	992.3	1,011.6	+1.9%
2024-02-14	2.39	2.46	+2.9%	991.3	1,013.5	+2.2%
2023-11-08	2.35	2.72	+15.7%	1,000.5	1,026.6	+2.6%